home / stock / cmnd / cmnd news

CMND News and Press, Caleminder Inc

Stock Information
Company Name: Caleminder Inc
Stock Symbol: CMND
Market: OTC
Menu
CMND CMND Quote CMND Short CMND News CMND Articles CMND Message Board
Get CMND Alerts

News, Short Squeeze, Breakout and More Instantly...
CMND - US Companies Moving the Markets, Morning edition
Fri, Jun 28, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 78.0% to $0.58749 on volume of 130,454,575 shares Ocean Power Technologies Inc. (OPTT) rose 29.6% to $0.2073 on volume of 51,927,154 shares Cosmos Health Inc. (COSM) rose 64.9% to $1.12 on volume of...
CMND - Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment

Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...

CMND - Clearmind secures exclusive rights to potential PSTD therapies

2024-06-20 10:01:06 ET More on CONMED CONMED Corporation 2024 Q1 - Results - Earnings Call Presentation CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript CONMED Non-GAAP EPS of $0.79 beats by $0.05, revenue of $312.3M beats by $5.58M CONMED Q1 2024 E...

CMND - Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment

Vancouver, Canada, June 20, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...
CMND - CMND Stock Earnings: Clearmind Medicine Reported Results for Q2 2024

2024-06-17 11:52:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clearmind Medicine (NASDAQ: CMND ) just reported results for the second quarter of 2024. Clearmind Medicine reported earnings per share of -28 cents. The company did n...

CMND - Clearmind Medicine advances MEAI-based alcohol substitute beverage program

2024-06-11 08:34:15 ET More on Clearmind Medicine Inc. Clearmind gains on exclusive global rights to psychedelic compounds for PTSD treatment Financial information for Clearmind Medicine Inc. Read the full article on Seeking Alpha For further details see: ...

CMND - Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink

Vancouver, Canada, June 11, 2024 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated...
CMND - Psychedelic stocks fall as FDA panel rejects MDMA therapy

2024-06-05 07:17:36 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Biggest stock...

CMND - FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD

2024-06-04 17:32:04 ET More on psychedelic drug companies ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Psychedelic sto...

CMND - Psychedelic stocks mixed as FDA comments on MDMA therapy

2024-05-31 10:43:44 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Mind Medicine...
Next 10